Histone deacetylase‐3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models
Open Access
- 11 May 2024
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 38 (10) , e23659
Abstract
HDAC3 inhibition has been shown to improve memory and reduce amyloid‐β (Aβ) in Alzheimer's disease (AD) models, but the underlying mechanisms are unclear. We investigated the molecular effects of HDAC3 inhibition on AD pathology, using in vitro and ex vivo models of AD, based on our finding that HDAC3 expression is increased in AD brains. For this purpose, N2a mouse neuroblastoma cells as well as organotypic brain cultures (OBCSs) of 5XFAD and wild‐type mice were incubated with various concentrations of the HDAC3 selective inhibitor RGFP966 (0.1–10 μM) for 24 h. Treatment with RGFP966 or HDAC3 knockdown in N2a cells was associated with an increase on amyloid precursor protein (APP) and mRNA expressions, without alterations in Aβ42 secretion. In vitro chromatin immunoprecipitation analysis revealed enriched HDAC3 binding at APP promoter regions. The increase in APP expression was also detected in OBCSs from 5XFAD mice incubated with 1 μM RGFP966, without changes in Aβ. In addition, HDAC3 inhibition resulted in a reduction of activated Iba‐1‐positive microglia and astrocytes in 5XFAD slices, which was not observed in OBCSs from wild‐type mice. mRNA sequencing analysis revealed that HDAC3 inhibition modulated neuronal regenerative pathways related to neurogenesis, differentiation, axonogenesis, and dendritic spine density in OBCSs. Our findings highlight the complexity and diversity of the effects of HDAC3 inhibition on AD models and suggest that HDAC3 may have multiple roles in the regulation of APP expression and processing, as well as in the modulation of neuroinflammatory and neuroprotective genes.Keywords
This publication has 54 references indexed in Scilit:
- Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative DiseasesCellular and Molecular Neurobiology, 2020
- BDNF signaling during the lifetime of dendritic spinesCell and tissue research, 2020
- Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patientsEuropean Neuropsychopharmacology, 2020
- Alzheimer's disease drug development pipeline: 2020Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2020
- Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndromeBiochemical and Biophysical Research Communications, 2014
- Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's diseaseLife Sciences, 2014
- Histone deacetylase inhibitors suppress immune activation in primary mouse microgliaJournal of Neuroscience Research, 2013
- Targeted proteomics for quantification of histone acetylation in Alzheimer's diseaseProteomics, 2012
- Distribution of histone deacetylases 1–11 in the rat brainJournal of Molecular Neuroscience, 2007
- Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor proteinNeuron, 1993